In addition, compared with the alteration frequency of other genes, like BRAF and EGFR, which had an alteration frequency of 8% and 7%, respectively, the frequency of FGFR3 genetic alterations (3%) across different cancer types was not that high which made our evaluation and analysis more challenging and difficult. This evidence concerns the gene BRAF and cancer.